Effect of Dialysate Temperature on Haemodynamic Stability and Haemodialysis Efficiency

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2013 by University Hospital, Ghent
Sponsor:
Information provided by (Responsible Party):
University Hospital, Ghent
ClinicalTrials.gov Identifier:
NCT00221598
First received: September 13, 2005
Last updated: January 29, 2013
Last verified: January 2013
  Purpose

Comparison between dialysate temperatures on haemodynamic stability and haemodialysis efficiency.


Condition Intervention
Acute Renal Failure
Chronic Renal Failure
Procedure: Haemodialysis with different dialysate temperatures

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Crossover Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Effect of Dialysate Temperature on Haemodynamic Stability and Haemodialysis Efficiency

Resource links provided by NLM:


Further study details as provided by University Hospital, Ghent:

Primary Outcome Measures:
  • Haemodynamic stability and tolerance [ Time Frame: t0 ] [ Designated as safety issue: No ]

Estimated Enrollment: 40
Study Start Date: June 2005
Estimated Study Completion Date: July 2013
Estimated Primary Completion Date: July 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: hemodialysis Procedure: Haemodialysis with different dialysate temperatures
Haemodialysis with different dialysate temperatures is used.

Detailed Description:

Comparison of 4 different dialysate temperatures for haemodialysis of patients with chronic renal failure.

Comparison of 3 different dialysate temperatures for haemodialysis of patients with acute renal failure.

Investigation of the efficiency of haemodialysis of patients with acute renal failure

  Eligibility

Ages Eligible for Study:   21 Years to 90 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Chronic renal failure
  • Acute renal failure
  • Aged between 21-90 years

Exclusion Criteria:

-

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00221598

Contacts
Contact: Annemieke Dhondt, MD, PhD + 32 9 332.45.79 annemie.dhondt@UGent.be

Locations
Belgium
University Hospital Ghent Recruiting
Ghent, Belgium, 9000
Contact: Annemieke Dhondt, MD, PhD    + 32 9 332.45.79    annemie.dhondt@UGent.be   
Sponsors and Collaborators
University Hospital, Ghent
Investigators
Principal Investigator: Annemieke Dhondt, MD, PhD University Hospital, Ghent
  More Information

Additional Information:
No publications provided

Responsible Party: University Hospital, Ghent
ClinicalTrials.gov Identifier: NCT00221598     History of Changes
Other Study ID Numbers: 2005/148
Study First Received: September 13, 2005
Last Updated: January 29, 2013
Health Authority: Belgium: Institutional Review Board

Additional relevant MeSH terms:
Acute Kidney Injury
Kidney Failure, Chronic
Renal Insufficiency
Kidney Diseases
Urologic Diseases
Renal Insufficiency, Chronic
Dialysis Solutions
Pharmaceutical Solutions
Therapeutic Uses
Pharmacologic Actions

ClinicalTrials.gov processed this record on August 28, 2014